Cellectis CLLS
NASDAQ CLLS
$1.40 -0.11 (-7.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cellectis (CLLS) Long-Term Deferred Tax (2018 - 2026)

Updated

Cellectis (CLLS) reported Long-Term Deferred Tax of $382,000 for Q2 2026, unchanged from $382,000 a year earlier and unchanged from the prior quarter.

Analysis

Cellectis (CLLS) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends

Dating back to Q4 2018, Cellectis' Long-Term Deferred Tax record includes 11 quarters.

  • By year, Long-Term Deferred Tax came in at $382,000 in FY2024.
  • Five-year quarterly Long-Term Deferred Tax spans a low of $382,000 in Q4 2024 and a high of $803,000 in Q3 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $382,000 (Q1 2026), $382,000 (Q4 2025) and $382,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cellectis 151.51 Mn -601.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 382,000.00
Mar 31, 2026 382,000.00
Dec 31, 2025 382,000.00
Sep 30, 2025 382,000.00
Jun 30, 2025 382,000.00
Mar 31, 2025 382,000.00
Dec 31, 2024 382,000.00
Sep 30, 2024 803,000.00
Dec 31, 2020 -144.10 Mn
Dec 31, 2019 -103.35 Mn
Dec 31, 2018 -66.82 Mn
API Access

Cellectis Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=CLLS&period=max&api_key=YOUR_API_KEY